Prime Minister of Kazakhstan Olzhas Bektenov held a meeting of the Board of Directors of NC Kazakh Invest JSC, which reviewed the current activities of the national company and plans for future work. 

Currently, Kazakh Invest supports 200 projects worth $27.3 billion with the creation of 68,800 jobs. More than 40 projects with foreign participation are expected to be launched this year. 

One of the most significant is the medical equipment manufacturing facility of the American company GE Healthcare in Astana. The project will localise the production of ultrasound and CT machines. This will make it possible not only to supply Kazakhstan's hospitals, but also to establish exports to other countries in the future. In addition, the company plans to organise educational programmes to improve the qualifications of staff of the republic's healthcare system.

Along with this, Swiss company Roche will launch production of anticancer drugs in Almaty with further prospects of export. 

Austrian company Lasselsberger will localise in Astana the production of ceramic tiles, dry building mixes and construction adhesive. The opening of the new plant will create more than 200 jobs and reduce the import dependence of the Kazakhstani market for these products. 

On the instructions of the Prime Minister of Kazakhstan, in further work Kazakh Invest will focus on attracting investors in promising projects on deep grain processing, production of demanded types of plastics, localisation of oil and gas equipment and other products with high added value.

"The Head of State has set a task to increase the volume of the economy to $450bn by 2029. At least $150bn of foreign investment must be attracted during this period. In this regard, every effort should be made to find and attract major investors to our country. Bold and non-standard solutions are needed," Olzhas Bektenov emphasised. 

#Olzhas Bektenov #The Prime Minister of the Republic of Kazakhstan #Investments